• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发用于社区居住老年人肌少症筛查的台湾肌少症风险评分(TRSS)。

Development of Taiwan Risk Score for Sarcopenia (TRSS) for Sarcopenia Screening among Community-Dwelling Older Adults.

机构信息

Department of Family Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.

Department of Orthopaedics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.

出版信息

Int J Environ Res Public Health. 2020 Apr 21;17(8):2859. doi: 10.3390/ijerph17082859.

DOI:10.3390/ijerph17082859
PMID:32326323
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7216229/
Abstract

The SARC-F questionnaire has been suggested by the European Working Group on Sarcopenia in Older People (EWGSOP) as a first-step screening tool for sarcopenia. However, the sensitivity to SARC-F is low among community-dwelling older adults. Therefore, this study aimed to develop a new prediction model for sarcopenia screening in the community setting. We conducted a cross-sectional analysis of data from the Taiwan Integration of Health and Welfare (TIHW) study. Covariates including comorbidities, socioeconomic status, social support, health behaviors, body composition, and serum biomarkers were collected for analysis. Sarcopenia was defined using handgrip strength and gait speed cut-off values suggested by the Asian Working Group for Sarcopenia. Risk scores for sarcopenia were estimated by stepwise logistic regression. Among 1025 participants (mean age, 71.95 ± 6.89 years), 179 (17.5%) had sarcopenia. Seven items, including age, female sex, receiving social assistance pension, absence of exercise, being underweight, abnormal fasting glucose levels, and abnormal creatinine levels were selected for the Taiwan Risk Scores for Sarcopenia (TRSS) with a cutoff value of 76 (sensitivity, 71.8%; specificity, 71.1%) and area under the curve (AUC) of 0.757. Our results suggested that the TRSS model could be applied cost-effectively in the community for early detection of sarcopenia.

摘要

SARC-F 问卷是由欧洲老年人肌肉减少症工作组(EWGSOP)提出的一种用于肌肉减少症初筛的工具。然而,它对社区老年人的肌肉减少症的敏感性较低。因此,本研究旨在为社区环境中的肌肉减少症筛查开发一种新的预测模型。我们对来自台湾健康与福利整合研究(TIHW)的数据进行了横断面分析。共收集了合并症、社会经济地位、社会支持、健康行为、身体成分和血清生物标志物等协变量进行分析。肌肉减少症的定义是使用亚洲肌肉减少症工作组建议的握力和步速截断值。通过逐步逻辑回归估计肌肉减少症风险评分。在 1025 名参与者(平均年龄 71.95±6.89 岁)中,179 人(17.5%)患有肌肉减少症。TRSS 包含 7 个项目,包括年龄、女性、领取社会援助养老金、缺乏运动、体重过轻、空腹血糖异常和肌酐水平异常,截断值为 76,敏感性为 71.8%,特异性为 71.1%,曲线下面积(AUC)为 0.757。我们的研究结果表明,TRSS 模型可在社区中以较低的成本有效应用于早期发现肌肉减少症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0efd/7216229/36924c2f486a/ijerph-17-02859-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0efd/7216229/36924c2f486a/ijerph-17-02859-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0efd/7216229/36924c2f486a/ijerph-17-02859-g001.jpg

相似文献

1
Development of Taiwan Risk Score for Sarcopenia (TRSS) for Sarcopenia Screening among Community-Dwelling Older Adults.开发用于社区居住老年人肌少症筛查的台湾肌少症风险评分(TRSS)。
Int J Environ Res Public Health. 2020 Apr 21;17(8):2859. doi: 10.3390/ijerph17082859.
2
SARC-F for sarcopenia screening in community-dwelling older adults: Are 3 items enough?用于社区居住老年人肌少症筛查的SARC-F:三项指标够吗?
Medicine (Baltimore). 2018 Jul;97(30):e11726. doi: 10.1097/MD.0000000000011726.
3
Sarcopenia in Korean Community-Dwelling Adults Aged 70 Years and Older: Application of Screening and Diagnostic Tools From the Asian Working Group for Sarcopenia 2019 Update.《亚洲肌少症工作组 2019 年更新版筛查和诊断工具在韩国社区居住 70 岁及以上老年人中的应用:肌少症》
J Am Med Dir Assoc. 2020 Jun;21(6):752-758. doi: 10.1016/j.jamda.2020.03.018. Epub 2020 May 5.
4
Comparing SARC-F with SARC-CalF to Screen Sarcopenia in Community Living Older Adults.比较 SARC-F 与 SARC-CalF 在社区居住的老年人群中筛查肌少症的效果。
J Nutr Health Aging. 2018;22(9):1034-1038. doi: 10.1007/s12603-018-1072-y.
5
Comparing Mini Sarcopenia Risk Assessment With SARC-F for Screening Sarcopenia in Community-Dwelling Older Adults.比较迷你肌少症风险评估与 SARC-F 在社区居住老年人中筛查肌少症的效果。
J Am Med Dir Assoc. 2019 Jan;20(1):53-57. doi: 10.1016/j.jamda.2018.04.012. Epub 2018 Jun 13.
6
Performance of SARC-F in Regard to Sarcopenia Definitions, Muscle Mass and Functional Measures.SARC-F 在肌少症定义、肌肉质量和功能测量方面的表现。
J Nutr Health Aging. 2018;22(8):898-903. doi: 10.1007/s12603-018-1067-8.
7
Comparison of Three Screening Methods for Sarcopenia in Community-Dwelling Older Persons.社区居住老年人肌少症三种筛查方法的比较。
J Am Med Dir Assoc. 2021 Apr;22(4):746-750.e1. doi: 10.1016/j.jamda.2020.05.041. Epub 2020 Jul 12.
8
SARC-F: A validation study with community-dwelling older Japanese adults.SARC-F:一项针对社区居住的日本老年成年人的验证研究。
Geriatr Gerontol Int. 2019 Nov;19(11):1172-1178. doi: 10.1111/ggi.13768. Epub 2019 Sep 18.
9
Screening Sarcopenia in Community-Dwelling Older Adults: SARC-F vs SARC-F Combined With Calf Circumference (SARC-CalF).社区居住老年人肌少症筛查:SARC-F 与 SARC-F 联合小腿围(SARC-CalF)。
J Am Med Dir Assoc. 2018 Mar;19(3):277.e1-277.e8. doi: 10.1016/j.jamda.2017.12.016.
10
Limitations of SARC-F in the diagnosis of sarcopenia in community-dwelling older adults.SARC-F 在社区居住的老年人肌少症诊断中的局限性。
Arch Gerontol Geriatr. 2020 Mar-Apr;87:103959. doi: 10.1016/j.archger.2019.103959. Epub 2019 Sep 24.

引用本文的文献

1
Loop Diuretics and Sarcopenia: A Potential Association.袢利尿剂与肌肉减少症:一种潜在关联
Muscles. 2023 Sep 22;2(4):317-326. doi: 10.3390/muscles2040024.
2
Risk prediction models for sarcopenia in elderly people: a systematic review and meta-analysis.老年人肌肉减少症的风险预测模型:一项系统评价和荟萃分析。
Front Med (Lausanne). 2025 Jun 2;12:1589583. doi: 10.3389/fmed.2025.1589583. eCollection 2025.
3
Bioelectrical impedance analysis-derived phase angle predicts possible Sarcopenia in patients on maintenance hemodialysis: a retrospective study.

本文引用的文献

1
German Version of SARC-F: Translation, Adaption, and Validation.SARC-F 的德译版:翻译、改编和验证。
J Am Med Dir Assoc. 2020 Jun;21(6):747-751.e1. doi: 10.1016/j.jamda.2019.12.011. Epub 2020 Jan 21.
2
Limitations of SARC-F in the diagnosis of sarcopenia in community-dwelling older adults.SARC-F 在社区居住的老年人肌少症诊断中的局限性。
Arch Gerontol Geriatr. 2020 Mar-Apr;87:103959. doi: 10.1016/j.archger.2019.103959. Epub 2019 Sep 24.
3
The effect of blood glucose regulation on sarcopenia parameters in obese and diabetic patients.
生物电阻抗分析得出的相位角可预测维持性血液透析患者的可能肌少症:一项回顾性研究。
BMC Nephrol. 2024 Oct 16;25(1):357. doi: 10.1186/s12882-024-03787-5.
4
Factors Associated with Sarcopenia among Elderly Individuals Residing in Community and Nursing Home Settings: A Systematic Review with a Meta-Analysis.社区和养老院老年人肌少症相关因素的系统评价:一项荟萃分析。
Nutrients. 2023 Oct 11;15(20):4335. doi: 10.3390/nu15204335.
5
Combination of Sarcopenia and Anemia Predicts Worse Outcome in Elderly Patients With Diffuse Large B-Cell Lymphoma.肌少症与贫血并存预示老年弥漫性大 B 细胞淋巴瘤患者预后更差。
In Vivo. 2023 Jul-Aug;37(4):1847-1856. doi: 10.21873/invivo.13276.
6
Use machine learning to help identify possible sarcopenia cases in maintenance hemodialysis patients.利用机器学习帮助识别维持性血液透析患者中可能的肌肉减少症病例。
BMC Nephrol. 2023 Feb 14;24(1):34. doi: 10.1186/s12882-023-03084-7.
7
Associated Factors of Sarcopenia in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis.社区居住老年人肌少症的相关因素:系统评价和荟萃分析。
Nutrients. 2021 Nov 27;13(12):4291. doi: 10.3390/nu13124291.
8
The Impact of Urate-Lowering Therapy in Post-Myocardial Infarction Patients: Insights From a Population-Based, Propensity Score-Matched Analysis.降尿酸治疗对心肌梗死后患者的影响:基于人群的倾向评分匹配分析的见解。
Clin Pharmacol Ther. 2022 Mar;111(3):655-663. doi: 10.1002/cpt.2473. Epub 2021 Nov 17.
血糖调节对肥胖和糖尿病患者肌肉减少症参数的影响。
Turk J Phys Med Rehabil. 2017 Nov 14;64(1):72-79. doi: 10.5606/tftrd.2018.1068. eCollection 2018 Mar.
4
Sarcopenia is Associated with Malnutrition but Not with Systemic Inflammation in Older Persons with Advanced CKD.肌少症与营养不良相关,但与晚期慢性肾脏病老年人的系统性炎症无关。
Nutrients. 2019 Jun 19;11(6):1378. doi: 10.3390/nu11061378.
5
Associations between Sarcopenia and Metabolic Risk Factors: A Systematic Review and Meta-Analysis.肌肉减少症与代谢风险因素之间的关联:一项系统评价和荟萃分析。
J Obes Metab Syndr. 2018 Sep 30;27(3):175-185. doi: 10.7570/jomes.2018.27.3.175.
6
International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management.国际肌少症临床实践指南(ICFSR):筛查、诊断和管理。
J Nutr Health Aging. 2018;22(10):1148-1161. doi: 10.1007/s12603-018-1139-9.
7
Sarcopenia: revised European consensus on definition and diagnosis.肌少症:定义和诊断的欧洲共识修订版。
Age Ageing. 2019 Jan 1;48(1):16-31. doi: 10.1093/ageing/afy169.
8
Importance of physical evaluation using skeletal muscle mass index and body fat percentage to prevent sarcopenia in elderly Japanese diabetes patients.使用骨骼肌质量指数和体脂百分比进行身体评估对预防老年日本糖尿病患者肌肉减少症的重要性。
J Diabetes Investig. 2019 Mar;10(2):322-330. doi: 10.1111/jdi.12908. Epub 2018 Sep 8.
9
Validation of the sarcopenia index to assess muscle mass in the critically ill: A novel application of kidney function markers.验证肌少症指数评估危重症患者肌肉量:肾功能标志物的新应用。
Clin Nutr. 2019 Jun;38(3):1362-1367. doi: 10.1016/j.clnu.2018.05.031. Epub 2018 Jun 8.
10
SARC-F for Screening of Sarcopenia Among Older Adults: A Meta-analysis of Screening Test Accuracy.SARC-F 用于筛查老年人肌少症:筛查试验准确性的荟萃分析。
J Am Med Dir Assoc. 2018 Aug;19(8):685-689. doi: 10.1016/j.jamda.2018.04.001. Epub 2018 May 31.